More than one in three people will develop some form of cancer during their lifetime, according to the NHS. In the UK, the four most common types of cancer are breast cancer, lung cancer, prostate cancer, and bowel cancer. However, there are over 200 types of cancer all in all, each of which have different symptoms. Most people will be aware of some symptoms of cancer, such as a lump somewhere on the body, but many other symptoms can be much less obvious.
Oncimmune (LON:ONC) is a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer. Oncimmune is changing how clinicians, researchers and patients view, diagnose and treat cancer. Our technology detects evidence of the body’s natural response to cancer, enabling detection 4 years or more before standard clinical diagnosis. Our tests facilitate clinical decision-making and are complementary to diagnostic technologies, making them valuable additions to established and new care pathways. We partner with leading developers and distributors to make our technology available globally.
